Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F06%3A00000596" target="_blank" >RIV/00216208:11120/06:00000596 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats
Original language description
Male heterozygous Ren-2 transgenic rats and Hannover Sprague-Dawley rats fed a normal or high-salt diet were either untreated or treated with the nonselective receptor ETA/ETB receptor blocker bosentan or the selective ETA receptor blocker, ABT-627, known as atrasentan
Czech name
Časný počátek blokády endotelinového receptoru a heterozygotních hypertenzních ren-2 potkanů
Czech description
Vliv neselektivní a selektivní (ETA) blokády na proteinurii, hypertroffi srdce, glomeruly a ET- tkáňové koncentrace u hypertenzních Ren-2 potkanů.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2006
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Vascular Pharmacology
ISSN
1537-1891
e-ISSN
—
Volume of the periodical
45
Issue of the periodical within the volume
3
Country of publishing house
US - UNITED STATES
Number of pages
8
Pages from-to
—
UT code for WoS article
000249173100010
EID of the result in the Scopus database
—